Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor Thompson

Showing results (101-110 of 308) with videos related to

Pageof 31
Sort By:
Annals of the American Thoracic Society|July 21, 2021
What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?Samuel M Brown, Ithan D Peltan, Christina Barkauskas, et al.
Critical Care (London, England)|March 2, 2006
Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort studyJames L Januzzi, Alexander Morss, Roderick Tung, et al.
Critical Care Medicine|August 2, 2007
Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndromeLorraine B Ware, Michael A Matthay, Polly E Parsons, et al.
Critical Care Medicine|April 14, 2010
Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shockCarolyn S Calfee, B Taylor Thompson, Polly E Parsons, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2013
Surrogate consent for genetic testing, the reconsent process, and consent for long-term outcomes in acute respiratory distress syndrome trialsAlexandra Smart, B Taylor Thompson, Dale M Needham, et al.
Critical Care Medicine|December 18, 2007
Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndromeEdnan K Bajwa, Paul D Boyce, James L Januzzi, et al.
American Journal of Clinical Pathology|March 13, 2014
Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stayJason M Baron, Elizabeth L Lewandrowski, James L Januzzi, et al.
Plos One|July 19, 2012
Prognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patientsMatthew B Rivara, Ednan K Bajwa, James L Januzzi, et al.
Pharmacy (Basel, Switzerland)|June 25, 2026
Bridging the Rural-Urban Divide: Independent Pharmacies and Women's Contraceptive AccessAmie M Ashcraft, Anthony Peluso, Taylor Thompson, et al.
Plos One|May 17, 2011
An NFKB1 promoter insertion/deletion polymorphism influences risk and outcome in acute respiratory distress syndrome among CaucasiansEdnan K Bajwa, Paul C Cremer, Michelle N Gong, et al.
Pageof 31

Showing results (101-110 of 308) with videos related to

Sort By:
Pageof 31
Annals of the American Thoracic Society|July 21, 2021
What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?Samuel M Brown, Ithan D Peltan, Christina Barkauskas, et al.
Critical Care (London, England)|March 2, 2006
Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort studyJames L Januzzi, Alexander Morss, Roderick Tung, et al.
Critical Care Medicine|August 2, 2007
Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndromeLorraine B Ware, Michael A Matthay, Polly E Parsons, et al.
Critical Care Medicine|April 14, 2010
Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shockCarolyn S Calfee, B Taylor Thompson, Polly E Parsons, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2013
Surrogate consent for genetic testing, the reconsent process, and consent for long-term outcomes in acute respiratory distress syndrome trialsAlexandra Smart, B Taylor Thompson, Dale M Needham, et al.
Critical Care Medicine|December 18, 2007
Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndromeEdnan K Bajwa, Paul D Boyce, James L Januzzi, et al.
American Journal of Clinical Pathology|March 13, 2014
Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stayJason M Baron, Elizabeth L Lewandrowski, James L Januzzi, et al.
Plos One|July 19, 2012
Prognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patientsMatthew B Rivara, Ednan K Bajwa, James L Januzzi, et al.
Pharmacy (Basel, Switzerland)|June 25, 2026
Bridging the Rural-Urban Divide: Independent Pharmacies and Women's Contraceptive AccessAmie M Ashcraft, Anthony Peluso, Taylor Thompson, et al.
Plos One|May 17, 2011
An NFKB1 promoter insertion/deletion polymorphism influences risk and outcome in acute respiratory distress syndrome among CaucasiansEdnan K Bajwa, Paul C Cremer, Michelle N Gong, et al.
Pageof 31